Buscar resultados de ensayos clínicos

Patrocinado por

Neurofibroma, Plexiform - 11 Studies Found

Estado Estudiar
Completed Nombre del estudio: Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas
Condición:
  • Neurofibromatosis Type 1
  • Plexiform Neurofibroma
  • Fecha: 2011-08-08
    Intervenciones: Drug: RAD001: Everolimus 10 mg of RAD001 will be self-administered orally once daily continuously for on
Completed Nombre del estudio: Study of Plexiform Neurofibromas in Neurofibromatosis Type 1
Condición:
  • Plexiform Neurofibromas
  • NF1

Fecha: 2000-11-03
Completed Nombre del estudio: PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)
Condición:
  • Neurofibroma, Plexiform
  • Precursor Cell Lymphoblastic Leukemia-L
    Fecha: 2015-03-17
    Intervenciones: Drug: PLX3397 Take oral drug daily for a 28 day cycle
Terminated Nombre del estudio: Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma
Condición:
  • Neurofibromatosis Type 1
  • Precancerous Condition

Fecha: 2003-05-06
Intervenciones:
  • Radiation: fludeoxyglucose F 18
  • Radiation:
Completed Nombre del estudio: Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas
Condición:
  • Neurofibromatosis Type 1
  • Precancerous Condition

Fecha: 2003-02-05
Intervenciones: Drug: pirfenidone
Completed Nombre del estudio: Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Condición:
  • Neurofibromatosis Type 1
  • Precancerous Condition

Fecha: 2002-02-14
Intervenciones:
  • Drug: Methotrexate Methotrexat
Completed Nombre del estudio: Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Condición: Cancer
Fecha: 2006-06-19
Completed Nombre del estudio: Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations
Condición: Cancer
Fecha: 2014-04-24
Intervenciones:
  • Drug: Trametinib Trametinib is
Completed Nombre del estudio: PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
Condición:
  • Neoplasm of Uncertain Malignant Potential
  • Unspecified Childhood Solid Tumor, Protocol Specif
    Fecha: 2005-11-11
    Intervenciones: Biological: PEG-interferon alfa-2a
Completed Nombre del estudio: AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors
Condición:
  • Neurofibromatosis 1
  • Neurofibromatosis Type 1
  • NF 1
    • Fecha: 2011-05-27
    Intervenciones: Drug: AZD6244 AZD6244 orally every 12 hours on continuous daily schedule for cycles of 28 days until una
Next >>>